ID
42224
Description
2012 ACCF / AHA Data Standard Renal Artery Disease data elements see http://www.ncbi.nlm.nih.gov/pubmed/22144570
Link
http://www.ncbi.nlm.nih.gov/pubmed/22144570
Keywords
Versions (5)
- 11/2/14 11/2/14 - Martin Dugas
- 11/2/14 11/2/14 - Martin Dugas
- 11/2/14 11/2/14 - Martin Dugas
- 11/3/14 11/3/14 - Martin Dugas
- 4/13/21 4/13/21 - Dr. rer. medic Philipp Neuhaus
Uploaded on
April 13, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Renal Artery Disease data elements
Renal Artery Disease data elements
- StudyEvent: ODM-Test
Description
Noninvasive Diagnostic Procedures
Alias
- UMLS CUI-1
- C0259832
Description
Duplex Ultrasound Date of procedure Artery imaged Indicate artery imaged: ● Right renal artery ● Left renal artery Peak systolic velocity ● Aorta ● Proximal, mid-, distal right renal artery ● Proximal, mid-, distal left renal artery Ratio of renal to aortic peak systolic velocities (left & right) ● 0%–59% ● 60%–99% ● Occluded Indicate side (right or left) and location of stenosis. Choose all that apply: ● Proximal ● Mid ● Distal Kidney size: Indicate maximum pole-to-pole renal length in centimeters. Resistive index (peak systolic velocity-end diastolic velocity)/peak systolic velocity ● Specify for right and left kidney Assessment of aorta: Identify atherosclerosis, stenosis, occlusion, and/or aneurysm of the abdominal aorta.
Data type
text
Alias
- UMLS CUI-1
- C0242845
Description
Magnetic Resonance Angiography Date of procedure Contrast (gadolinium) use: yes/no Location of stenosis: Indicate side (right or left) and location of stenosis. Choose all that apply: ● Proximal ● Mid ● Distal Location of stenosis: specific location in renal artery Indicate side (right or left) and location of stenosis. Choose all that apply: ● Main renal artery ostium ● Main renal artery postostium (>1 cm from ostium) ● Segmental renal artery ● Intrarenal renal artery Artery stenosis: Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment Aorta: Identify atherosclerosis, stenosis, occlusion, and/or aneurysm of the abdominal aorta. Kidney size: Indicate the maximum pole-to-pole renal length in centimeters. Symmetry of renal perfusion: Consistency and equality of renal blood flow in both kidneys Symmetry of renal excretion: Symmetry of rate of excretion of contrast agent from kidney Renal artery morphology ● fibromuscular dysplasia (FMD) ● Atherosclerosis
Data type
text
Alias
- UMLS CUI-1
- C0243032
Description
Computed Tomographic Angiography Date of procedure Indicate the type of contrast used. Choose 1 of the following: ● Ionic contrast ● Nonionic contrast; specify: — Monomer — Dimer Contrast volume [ml] Location of stenosis: left/right ● Main renal artery ostium ● Main renal artery postostium (>1 cm from ostium) ● Segmental renal artery ● Intrarenal renal artery Artery stenosis: Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment Aorta: Identify atherosclerosis, stenosis, occlusion, and/or aneurysm of the abdominal aorta. Kidney size: Indicate the maximum longitudinal renal length in centimeters. Symmetry of renal perfusion: Consistency and equality of renal blood flow in both kidneys Symmetry of renal excretion: Symmetry of rate of excretion of contrast agent from kidney Renal artery morphology ● FMD ● Atherosclerosis Captopril Renography Date of procedure Operator name Symmetry: Indicate whether there is equal uptake and excretion of radiotracer within kidneys. Renogram curve: Absolute time-activity curves pre- and postcaptopril, including peak and time to half-activity after peak The time activity curve consists of the ● Vascular phase ● Secretory or functional phase ● Excretory phase
Data type
text
Alias
- UMLS CUI-1
- C1536105
Description
Diagnostic Procedures: Invasive
Alias
- UMLS CUI-1
- C0430022
- UMLS CUI-2
- C0205281
Description
Catheter-Based Angiography Date of procedure Operator name Vascular access site Contrast agent Indicate the contrast agent used: ● Iodinated — Ionic — Nonionic X Monomer X Dimer ● Noniodinated (CO2) Contrast volume Fluoroscopy time: Indicate the total fluoroscopy time recorded during the procedure to the nearest 0.10 min. Catheter position ● Selective ● Nonselective Renal perfusion: Were all renal arteries identified (ie, are there unexplained perfusion defects in the nephrogram phase)? Location of stenosis: specific location in renal artery Indicate the side (right or left) and location of stenosis. Choose all that apply: ● Main renal artery ostium ● Main renal artery postostium (>1 cm from ostium) ● Segmental renal artery ● Intrarenal renal artery Artery stenosis Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment Aorta: Identify atherosclerosis, stenosis, occlusion, and/or aneurysm of the abdominal aorta. Kidney size: Maximum longitudinal renal length in centimeters Symmetry of renal perfusion: Assess the consistency and equality of renal blood flow in both kidneys. Renal artery morphology ● FMD ● Atherosclerosis Complications: Indicate complications related to the diagnostic procedure. If a concurrent endovascular procedure is performed, report under endovascular complications. Choose all that apply: ● Pseudoaneurysm ● AV fistula ● Hematoma ● Dissection ● Vessel thrombosis ● Vessel perforation ● Atheromatous embolization ● Contrast nephropathy ● Contrast hypersensitivity ● Requirement of intervention to prevent permanent impairment/damage ● None
Data type
text
Alias
- UMLS CUI-1
- C0002979
Description
Medical therapies
Alias
- UMLS CUI-1
- C0013227
Description
Indicate name, dose, frequency of specific antihypertensive agent(s) used; address the use of angiotensin-converting enzyme inhibitors/angiotensin II receptor antagonists.
Data type
text
Alias
- UMLS CUI-1
- C0585941
Description
Indicate the name, dose, and frequency of specific lipid-lowering agent(s) used.
Data type
text
Alias
- UMLS CUI-1
- C0585943
Description
Indicate the name, dose, and frequency of specific antiplatelet agent(s) used.
Data type
text
Alias
- UMLS CUI-1
- C1096021
Description
Invasive Therapeutic Procedures
Alias
- UMLS CUI-1
- C0087111
Description
Renal Artery Angioplasty/Stenting Date of procedure Operator name Angioplasty/stenting Choose 1 of the following: ● Balloon angioplasty alone ● Stent Balloon length [mm] Nominal balloon diameter: Indicate the diameter of the balloon at initial inflation and final inflation in millimeters. Target renal artery: Indicate whether the target vessel for the procedure is the right or left renal artery. Current procedure part of clinical trial: Indicate whether the procedure is part of a clinical trial. Choose one: ● Yes If yes, indicate the trial type: — IDE — Postmarket approval — Other (specify) ● No Anesthesia: Indicate if the patient received general anesthesia, conscious sedation, local anesthesia, or no anesthesia during the current procedure.
Data type
text
Alias
- UMLS CUI-1
- C1282893
- UMLS CUI-2
- C1532969
Description
Procedure Indications and Anatomic Variables Clinical indications ● Hypertension ● Renal insufficiency ● CHF/pulmonary edema ● Angina pectoris Restenosis in target vessel after prior renal stent Note if the indication for the current procedure is restenosis in the target renal artery that was previously treated with angioplasty and/or a stent. ● Renal artery restenosis is defined as >50% diameter stenosis at or adjacent to the site previously treated with balloon angioplasty or a stent. Contrast volume: Indicate the volume of iodinated contrast injected during the procedure in milliliters. Fluoroscopy time: Indicate the total fluoroscopy time recorded during the procedure to the nearest 0.10 min. The time recorded should include the total time for the procedure. Contralateral renal artery occlusion: Indicate if there is known 100% occlusion of the patient’s contralateral renal artery. Spontaneous aortic or renal artery dissection: Indicate if the patient has had a spontaneous renal artery dissection before the current procedure. Procedure arterial access site Indicate the primary arterial access site used to perform the renal artery stenting procedure. Note the location (right/left): ● Femoral ● Brachial ● Radial ● Axillary Arterial access closure method ● List methods and devices in chronological order of closure. ● Indicate the method used to achieve hemostasis: — Device — Nondevice (such as manual compression)
Data type
text
Description
Lesions Target lesion location List the following: ● Ostial ● Proximal ● Mid ● Distal ● Intrarenal Visible thrombus present: Indicate if the target lesion contains thrombus as assessed by baseline angiography and implied by the presence of filling defect. Calcification: Indicate if calcification is present. If present, specify the location. Choose 1 of the following: ● None ● Mild ● Moderate ● Severe Lesion length: Indicate the length of the target lesion in millimeters as assessed by baseline angiography. Minimal luminal diameter (MLD): Indicate the MLD of the target lesion in millimeters as assessed by baseline angiography. Minimal luminal diameter is defined as the minimum luminal diameter derived from the angiographic view that shows the tightest point of the stenosis. Diameter of distal renal artery: Indicate the diameter of the nontapering distal segment of the renal artery measured at the intended landing zone of the distal edge of the stent. Preprocedure percent stenosis of renal artery Indicate the severity of stenosis by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment Lesion treatment incomplete or aborted: Indicate if the lesion treatment was incomplete or aborted. Choose 1 of the following: ● Yes — If yes, note the reasons: X Failure to gain vascular access X Failure to engage ostium with guide catheter X Unable to cross with guidewire X Unable to deploy stent X Failure to confirm significant stenosis X Unable to cross balloon X Cardiac ischemia X Unable to deploy device X Hypotension X Hypertension X Unable to deliver stent X Other ● No Embolic protection attempted: Indicate if the operator tried to use an EPD. Choose 1 of the following: ● Yes — If yes, indicate if predilatation before the balloon or stent was performed or not. — If yes, list EPD in chronological order. Note if successfully deployed. ● No Stent malposition: Indicate if the stent was deployed in a location or position other than that for which it was intended. Final MLD: Indicate the final residual lumen diameter in millimeters. Final percent stenosis of renal artery: Indicate the percent stenosis post procedure by quantitative analysis using the formula 100x(1-minimum lumen diameter)/maximum diameter of reference segment
Data type
text
Alias
- UMLS CUI-1
- C0221198
Description
Device Number of stents used (per artery) ● 1 ● >1 Stent type: Indicate the type of stent used. Choose all that apply: ● Balloon expandable ● Self-expanding ● Drug eluting ● Covered Stent brand name: Indicate the brand name of the stent used. Stent model: Indicate the model number of the stent used. Stent manufacturer: Indicate the manufacturer of the stent used. Stent length: Indicate the length of the stent used in millimeters. Stent diameter: Indicate the diameter of the stent used in millimeters.
Data type
text
Alias
- UMLS CUI-1
- C2825207
Description
Renal Artery Surgical Revascularization Date of procedure Indicate the date of the procedure (mo/d/y). Indications for the procedure Consider indications for renal artery revascularization. Choose all that apply: ● Clinical indications — Hypertension — Renal insufficiency — CHF/pulmonary edema — Angina pectoris ● Surgery-specific indications — Repetitive failure of renal artery angioplasty/stent — Need for aortic surgery (ie, AAA repair) Surgical procedures Indicate the surgical revascularization procedure: ● Renal artery endarterectomy ● Aortorenal bypass with either saphenous vein or synthetic material ● Extra-anatomic bypass: hepatorenal, splenorenal, ileorenal
Data type
text
Alias
- UMLS CUI-1
- C0035065
- UMLS CUI-2
- C0581603
Description
Outcomes of Endovascular/Open Surgical Procedures
Description
Indicate the period at which outcome measures are assessed. Choose all that apply:
Data type
integer
Alias
- UMLS CUI-1
- C2986292
Description
Indicate postoperative clinical events or conditions associated with the endovascular procedure. Choose all that apply:
Data type
text
Alias
- UMLS CUI-1
- C0009566
- UMLS CUI-2
- C2936204
Description
Indicate complications of open surgery. Choose all that apply: ● Major complication — Death — MI (also see cardiovascular complications below): X Prolonged hospitalization X Loss of limb or function of organ system X Persistent or significant disability or incapacity X Vessel thrombosis X Vessel rupture — Stroke X Cerebral X Spinal cord stroke — Other life-threatening major complication (specify) X Seroma X Hematoma X Mesenteric ischemia X Renal failure X Pneumonia X Atheromatous embolization X DVT X Graft thrombosis X Atheromatous embolization X Contrast nephropathy X Contrast hypersensitivity X Infection X Requirement for intervention to prevent permanent impairment/damage — Minor complication (specify)
Data type
text
Alias
- UMLS CUI-1
- C0009566
- UMLS CUI-2
- C0348025
Description
Indicate the length of stay in the hospital in number of days.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI-1
- C0023303
Description
Indicate the patient’s discharge status. Choose 1 of the following: ● Discharged to home or self-care — This includes discharge to home; jail or law enforcement; home on oxygen if DME only; any other DME only; group home, foster care, and other residential care arrangements; outpatient programs such as partial hospitalization or outpatient chemical dependency programs; assisted living facilities that are not state designated. ● Discharged/transferred to short-term general hospital for inpatient care ● Discharged/transferred to SNF with Medicare certification in anticipation of skilled care ● Discharged/transferred to ICF ● Discharged/transferred to standard rehabilitation facility ● Discharged/transferred to ventilator rehabilitation facility ● Discharged/transferred to another type of healthcare institution other than the above ● Patient died
Data type
text
Alias
- UMLS CUI-1
- C0586514
Description
Patient education/Counseling
Description
Verbal and written medication instructions provided to patient and/or family
Data type
text
Alias
- UMLS CUI-1
- C2064717
Description
Verbal and written instructions provided to patient and/or family (by physician or nurse) regarding new or worsening symptoms and when to call the physician
Data type
text
Description
Advice given or discussion held with the patient and/or family about diet counseling in relation to lowering cardiovascular risk. May include ● Sodium restriction ● Fluid restriction ● Referral to dietitian for weight management and/or advanced nutritional instruction ● Other (specify)
Data type
text
Alias
- UMLS CUI-1
- C0204932
Description
Advice given or discussion held with patient (by physician, nurse, or other personnel) about the importance of stopping smoking. May include ● Counseling (may be basic or advanced) ● Written materials ● Referral to smoking cessation program ● Drugs to help with smoking cessation
Data type
text
Alias
- UMLS CUI-1
- C1095963
Description
Advice given or discussion held with patient and/or family about activity level and restrictions in activity and/or exercise recommendations
Data type
text
Description
Follow-up
Alias
- UMLS CUI-1
- C1522577
Description
Documentation of evaluation of the patient after discharge. Indicate all of the following that apply: ● Physical examination ● Imaging (eg, ultrasound, MR, CT)
Data type
text
Description
Documentation of evaluation of the patient after discharge. Indicate all of the following that apply: ● Physical examination ● Imaging (eg, ultrasound, MR, CT)
Data type
text
Description
Clinical Outcomes
Alias
- UMLS CUI-1
- C0085565
Description
Indicate the period at which outcome measures are assessed. Choose all that apply:
Data type
integer
Description
● Indicate systolic and diastolic blood pressure ● Categories of blood pressure — Reduction in systolic blood pressure by 20 mm Hg — Reduction in diastolic blood pressure by 10 mm Hg — Normotensive versus hypertensive ● Indicate changes in the number of antihypertensive medications (specify medications)
Data type
text
Alias
- UMLS CUI-1
- C0005823
Description
Monitor creatinine and estimated/calculated GFR
Data type
integer
Alias
- UMLS CUI-1
- C0232804
Description
Morbidity/mortality
Data type
integer
Alias
- UMLS CUI-1
- C0220880
Similar models
Renal Artery Disease data elements
- StudyEvent: ODM-Test
C1565662 (UMLS CUI-2)
C0205281 (UMLS CUI-2)
C1532969 (UMLS CUI-2)
C0581603 (UMLS CUI-2)
C2936204 (UMLS CUI-2)
C0348025 (UMLS CUI-2)